NIH: Innovative Research in Cancer Nanotechnology (IRCN) (R01) [PAR-17-240]


The purpose of this funding opportunity announcement (FOA) on Innovative Research in Cancer Nanotechnology (IRCN) is to expand the fundamental understanding of the processes pertinent to the use of nanotechnology in cancer. The goal of IRCN projects is to generate new fundamental knowledge associated with the development of nanotechnology-based solutions to major problems in cancer-biology and/or oncology. The outcomes of IRCN-supported projects should inspire and aid the ultimate development of innovative, clinically relevant nanotechnology solutions for cancer (although prospective clinical translation of the IRCN findings remains beyond the scope of this FOA). Projects supported by the IRCN initiative should incorporate multidisciplinary research efforts in biology/oncology, chemistry, physics, and/or engineering.

For more info and to apply, visit https://grants.nih.gov/grants/guide/pa-files/PAR-17-240.html